Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Oct;3(4):374-387.
doi: 10.18001/TRS.3.4.1.

Effect of Flavors and Modified Risk Messages on E-cigarette Abuse Liability

Affiliations

Effect of Flavors and Modified Risk Messages on E-cigarette Abuse Liability

Andrew J Barnes et al. Tob Regul Sci. 2017 Oct.

Abstract

Objectives: To measure e-cigarettes' abuse liability compared to conventional tobacco cigarettes under flavor and message conditions amenable to regulation.

Methods: Two studies used 2×2 within-subjects designs with factors of e-cigarette flavor (Study 1: tobacco vs. menthol; Study 2: cherry vs. unflavored) and message (Study 1: reduced harm vs. no message; Study 2: reduced exposure to carcinogens vs. no message) with cigarette smokers (N(total) = 36). Linear mixed effects models assessed abuse liability for tobacco products. Outcomes included the price after which consumption is zero (the maximum amount participants would pay for a tobacco product) from the multiple choice procedure (MCP) and cigarette purchase task (CPT) and demand elasticity (price sensitivity) from the CPT.

Results: In the MCP, the price where consumption reached zero was significantly lower in all e-cigarette conditions except tobacco flavor (message or no message) compared to cigarettes (p < .05 each). Demand elasticity was significantly higher for menthol/no message and unflavored/reduced exposure message conditions relative to cigarettes (p < .05 each).

Conclusions: Flavors and modified risk messages included with e-cigarettes may affect e-cigarette abuse liability among smokers, suggesting regulatory pathways to influence demand for conventional and alternative tobacco products.

Keywords: abuse liability; e-cigarette; flavor; risk messages.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Statement The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Examples of Multiple Choice Procedure and Cigarette Purchase Task for a Reduced Harm Menthol-flavored E-cigarette.
Figure 2
Figure 2
Multiple Choice Procedure Predicted Mean Crossover Points by Study and Condition. Note: Crossover points reflect mean (+SEM) in US $ (United States dollars). Asterisks (*) indicate a significant difference relative to own-brand cigarettes using linear mixed models adjusted for own-brand cigarette menthol/non-menthol preference and MCP trial (1–5) and brackets indicate a significant pairwise difference between those 2 e-cigarette conditions using Wald test (ps < .05).

References

    1. Callahan-Lyon P. Electronic cigarettes: human health effects. Tob Control. 2014;23(Suppl 2):ii36–40. - PMC - PubMed
    1. Food and Drug Administration. 21 CFR parts 1100, 1140, and 1143. Deeming tobacco products to be subject to the federal Food, Drug, and Cosmetic Act, as amended by the Family Smoking Prevention and Tobacco Control Act; restrictions on the sale and distribution of tobacco products and required warning statements for tobacco products; final rule. Federal Register. 2016;81(90):28974–29106. - PubMed
    1. Food and Drug Administration. Modified Risk Tobacco Product applications. Draft guidance. United States Department of Health and Human Services, Food and Drug Administration, Center for Tobacco Products; 2012.
    1. Food and Drug Administration. Guidance for industry: assessment of abuse potential of drugs. Draft guidance. United States Department of Health and Human Services, Food and Drug Administration; 2010.
    1. Jacobs E, Bickel WK. Modeling drug consumption in the clinic using simulation procedures: demand for heroin and cigarettes in opioid-dependent outpatients. Exp Clin Psychopharmacol. 1999;7(4):412–426. - PubMed

LinkOut - more resources